These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 15625895

  • 1. [Study on serum soluble interleukin-6 receptor levels in patients with malignant hematological diseases].
    Li D, Yang J, Cui W, Ma C, Ma C, Ji E, Li J, Li G, Ma C.
    Zhonghua Xue Ye Xue Za Zhi; 1997 Nov; 18(11):577-80. PubMed ID: 15625895
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma.
    Stasi R, Brunetti M, Parma A, Di Giulio C, Terzoli E, Pagano A.
    Cancer; 1998 May 15; 82(10):1860-6. PubMed ID: 9587117
    [Abstract] [Full Text] [Related]

  • 3. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May 15; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 4. [Soluble interleukin-6 receptors in the serum in multiple myeloma].
    Scudla V, Kubalová D, Bacovský J, Lukes J, Vavrdová V.
    Cas Lek Cesk; 1996 Nov 20; 135(22):719-22. PubMed ID: 8998823
    [Abstract] [Full Text] [Related]

  • 5. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep 20; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 6. Serum interleukin-6 receptor in polymyalgia rheumatica: a potential marker of relapse/recurrence risk.
    Pulsatelli L, Boiardi L, Pignotti E, Dolzani P, Silvestri T, Macchioni P, Cantini F, Salvarani C, Facchini A, Meliconi R.
    Arthritis Rheum; 2008 Aug 15; 59(8):1147-54. PubMed ID: 18668607
    [Abstract] [Full Text] [Related]

  • 7. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients.
    Sadeghi M, Daniel V, Naujokat C, Mehrabi A, Opelz G.
    Transplantation; 2006 Jun 27; 81(12):1716-24. PubMed ID: 16794539
    [Abstract] [Full Text] [Related]

  • 8. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
    Li Y, Wang Y, Qi L.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan 27; 36(1):18-9. PubMed ID: 11778537
    [Abstract] [Full Text] [Related]

  • 9. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
    Toren A, Novick D, Ackerstein A, Or R, Slavin S, Nagler A.
    Bone Marrow Transplant; 1996 Oct 27; 18(4):721-4. PubMed ID: 8899186
    [Abstract] [Full Text] [Related]

  • 10. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan 27; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 11. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy.
    Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Maruo N, Taga T, Kishimoto T, Klein B.
    Eur J Immunol; 1993 Apr 27; 23(4):820-4. PubMed ID: 8458373
    [Abstract] [Full Text] [Related]

  • 12. [Examination and evaluation of sIL-6R, sgp130 in serum in patients with chronic hepatopathy].
    Shang J, Xu Y, Zhang H.
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr 27; 8(2):87-8. PubMed ID: 10861111
    [Abstract] [Full Text] [Related]

  • 13. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martín-Mola E, Fontan G.
    J Rheumatol; 1997 Nov 27; 24(11):2069-75. PubMed ID: 9375862
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE.
    Rheumatology (Oxford); 2006 Dec 27; 45(12):1485-9. PubMed ID: 16690760
    [Abstract] [Full Text] [Related]

  • 15. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E, Terpos E, Papaioannou M, Hatjileontis C, Kaloutsi V, Galaktidou G, Gerotziafas G, Christakis J, Zervas K.
    Hematol Oncol; 2004 Dec 27; 22(4):159-68. PubMed ID: 15991268
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T, Sato S, Hasegawa M, Ihn H, Takehara K.
    J Rheumatol; 2000 Aug 27; 27(8):1917-21. PubMed ID: 10955333
    [Abstract] [Full Text] [Related]

  • 17. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
    Xu J, Wang B.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb 27; 19(2):82-4. PubMed ID: 10921108
    [Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M, Nikolaou C, Tavernarakis A, Alexandri NM, Rentzos M, Chatzipanagiotou S, Cambouri C, Vassilopoulos D.
    Immunol Lett; 2004 Jul 15; 94(3):183-9. PubMed ID: 15275965
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug 15; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 20. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V, Budíková M, Bacovský J, Opíchalová D, Farbiaková V.
    Cas Lek Cesk; 2000 Jul 05; 139(13):401-6. PubMed ID: 10971970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.